Cargando…

Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy

BACKGROUND: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Plaque brachytherapy (PRT) is widely accepted as an effective globe-conserving treatment modality for UM. However, local treatment failure and complications lead to the enucleation of irradiated eyes. We con...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Heng, Zhang, Ruiheng, Wang, Yining, Chen, Rongtian, Liu, Yueming, Li, Yang, Wei, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994292/
https://www.ncbi.nlm.nih.gov/pubmed/35397506
http://dx.doi.org/10.1186/s12886-022-02387-x
_version_ 1784684078144946176
author Wang, Heng
Zhang, Ruiheng
Wang, Yining
Chen, Rongtian
Liu, Yueming
Li, Yang
Wei, Wenbin
author_facet Wang, Heng
Zhang, Ruiheng
Wang, Yining
Chen, Rongtian
Liu, Yueming
Li, Yang
Wei, Wenbin
author_sort Wang, Heng
collection PubMed
description BACKGROUND: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Plaque brachytherapy (PRT) is widely accepted as an effective globe-conserving treatment modality for UM. However, local treatment failure and complications lead to the enucleation of irradiated eyes. We conducted this study to explore the causes and long-term prognosis for UM patients who accepted secondary enucleation after plaque radiotherapy. METHODS: This was a retrospective cohort study. Data of patients who underwent secondary enucleation for UM after plaque radiotherapy, from July 2007 to July 2019, at Beijing Tongren Hospital were analyzed. Kaplan–Meier analysis was performed to assess the probability of indications, metastasis, and metastasis-related death. Cox regression analysis was used to analyze associations of the prognostic factors. RESULTS: Eight hundred and eighty patients were clinically diagnosed with uveal melanoma and initially treated by iodine-125 plaque radiotherapy, 132 of whom underwent secondary enucleation and pathological examination in the same hospital. Fifty-two (39.4%) eyes were enucleated simply because of uncontrollable neovascular glaucoma (NVG). Forty-four (33.3%) patients suffered from tumor recurrence. Tumor non-response occurred in 18 (13.6%) cases. Ten (7.6%) eyes received enucleation entirely due to other types of glaucoma. Failure to preserve the eyes for other reasons occurred in eight (6.1%) patients. At a median follow-up of 58.1 [IQR: 40.9–90.5] months, the systemic spread was detected in 45 (34.1%) patients, and 38 of them died. On multivariate analysis, tumor largest basal diameter (HR 1.15 [95% CI: 1.01, 1.31]), tumor non-response (HR 7.22 [95% CI: 2.63, 19.82]), and recurrence (HR 3.29 [95% CI: 1.54, 7.07]) were risk factors for metastasis. Increased age (HR 1.54 [95% CI: 1.07, 2.23]), tumor non-response (HR 7.91 [95% CI: 2.79, 22.48]), and recurrence (HR 3.08 [95% CI: 1.13, 7.23]) were risk factors for metastasis-related death. CONCLUSIONS: NVG was the major reason for secondary enucleation for Chinese UM patients after PRT. Tumor non-response and recurrence were associated with a significantly higher risk of long-term metastasis and metastasis-related death.
format Online
Article
Text
id pubmed-8994292
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89942922022-04-10 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy Wang, Heng Zhang, Ruiheng Wang, Yining Chen, Rongtian Liu, Yueming Li, Yang Wei, Wenbin BMC Ophthalmol Article BACKGROUND: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Plaque brachytherapy (PRT) is widely accepted as an effective globe-conserving treatment modality for UM. However, local treatment failure and complications lead to the enucleation of irradiated eyes. We conducted this study to explore the causes and long-term prognosis for UM patients who accepted secondary enucleation after plaque radiotherapy. METHODS: This was a retrospective cohort study. Data of patients who underwent secondary enucleation for UM after plaque radiotherapy, from July 2007 to July 2019, at Beijing Tongren Hospital were analyzed. Kaplan–Meier analysis was performed to assess the probability of indications, metastasis, and metastasis-related death. Cox regression analysis was used to analyze associations of the prognostic factors. RESULTS: Eight hundred and eighty patients were clinically diagnosed with uveal melanoma and initially treated by iodine-125 plaque radiotherapy, 132 of whom underwent secondary enucleation and pathological examination in the same hospital. Fifty-two (39.4%) eyes were enucleated simply because of uncontrollable neovascular glaucoma (NVG). Forty-four (33.3%) patients suffered from tumor recurrence. Tumor non-response occurred in 18 (13.6%) cases. Ten (7.6%) eyes received enucleation entirely due to other types of glaucoma. Failure to preserve the eyes for other reasons occurred in eight (6.1%) patients. At a median follow-up of 58.1 [IQR: 40.9–90.5] months, the systemic spread was detected in 45 (34.1%) patients, and 38 of them died. On multivariate analysis, tumor largest basal diameter (HR 1.15 [95% CI: 1.01, 1.31]), tumor non-response (HR 7.22 [95% CI: 2.63, 19.82]), and recurrence (HR 3.29 [95% CI: 1.54, 7.07]) were risk factors for metastasis. Increased age (HR 1.54 [95% CI: 1.07, 2.23]), tumor non-response (HR 7.91 [95% CI: 2.79, 22.48]), and recurrence (HR 3.08 [95% CI: 1.13, 7.23]) were risk factors for metastasis-related death. CONCLUSIONS: NVG was the major reason for secondary enucleation for Chinese UM patients after PRT. Tumor non-response and recurrence were associated with a significantly higher risk of long-term metastasis and metastasis-related death. BioMed Central 2022-04-09 /pmc/articles/PMC8994292/ /pubmed/35397506 http://dx.doi.org/10.1186/s12886-022-02387-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Article
Wang, Heng
Zhang, Ruiheng
Wang, Yining
Chen, Rongtian
Liu, Yueming
Li, Yang
Wei, Wenbin
Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
title Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
title_full Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
title_fullStr Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
title_full_unstemmed Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
title_short Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
title_sort retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994292/
https://www.ncbi.nlm.nih.gov/pubmed/35397506
http://dx.doi.org/10.1186/s12886-022-02387-x
work_keys_str_mv AT wangheng retrospectiveanalysisofsecondaryenucleationforuvealmelanomaafterplaqueradiotherapy
AT zhangruiheng retrospectiveanalysisofsecondaryenucleationforuvealmelanomaafterplaqueradiotherapy
AT wangyining retrospectiveanalysisofsecondaryenucleationforuvealmelanomaafterplaqueradiotherapy
AT chenrongtian retrospectiveanalysisofsecondaryenucleationforuvealmelanomaafterplaqueradiotherapy
AT liuyueming retrospectiveanalysisofsecondaryenucleationforuvealmelanomaafterplaqueradiotherapy
AT liyang retrospectiveanalysisofsecondaryenucleationforuvealmelanomaafterplaqueradiotherapy
AT weiwenbin retrospectiveanalysisofsecondaryenucleationforuvealmelanomaafterplaqueradiotherapy